Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-30
2011-08-30
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08008281
ABSTRACT:
Compositions and methods for the treatment of malignancy and chronic viral infection are disclosed.
REFERENCES:
patent: 5804567 (1998-09-01), Cheng et al.
patent: 5902610 (1999-05-01), Hausheer et al.
patent: 5922689 (1999-07-01), Shaw
patent: 6451840 (2002-09-01), Munn et al.
patent: 6482416 (2002-11-01), Munn et al.
patent: 2001/0001040 (2001-05-01), Munn et al.
patent: 2007/0173524 (2007-07-01), Prendergast et al.
patent: 1444935 (2003-10-01), None
patent: 98/18490 (1998-05-01), None
patent: 00/66764 (2000-11-01), None
patent: WO 01/28493 (2001-04-01), None
patent: 02/18368 (2002-03-01), None
patent: 2005/034940 (2005-04-01), None
patent: 2005/037257 (2005-04-01), None
patent: 2005/037779 (2005-04-01), None
Peckham et al ‘Oxford Textbook of Oncology’ Oxford Univerity Press, vol. 1, p. 451, 1995.
Sabol et al ‘Cytotoxic effect of cruciferous phytoalexins agains murine L1210 leukemia and B16 melanoma’ Biologia Bratislava, 55(6), 701-707-2000.
Masuda, M., et al., “Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction,” J. Exp. Therap. Oncol., 2:350-359, (2002).
Database Biosis [Online] Liu, J-K., “Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways,” Arch. Pharm. Res., 25(5):561-571, Biosciences Information Service, Philadelphia, PA, (Oct. 2002). [Abstract].
Cover, C.M., et al., “Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells,” Cancer Res., 59:1244-1251, (Mar. 15, 1999).
Jakse, R., et al., “A simple synthesis of aplysinopsin analogues by dimethylamine substitution in N,N-(dimethylamino) methylidene derivatives of five-membered heterocycles,” Tetrahedron, 57:8395-8403, (2001).
Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, 1996, pp. 1295-1296.
Mehta, R.G., et al. “Structure-activity relationships of brassinin in preventing the development of carcinogen-induced mammary lesions in organ culture.” Anticancer Research, 14: 1209-1214 (1994).
Mehta, R.G., et al. “Cancer-chemopreventive activity of brassinine, a phytoalexin from cabbage.” Carcinogenesis, 16 (2): 399-404 (1995).
Golub, T.R, et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring.” Science, 286: 531-537 (Oct. 15, 1999).
Suganuma et al., “Synergistic Effects of (-30 )-Epigallocatechin Gallate with (-30 )-Epicatechin, Sulindac, or Tamoxifin on Cancer-preventive Activity in the Human Lung Cancer Cell Line PC-9,” Cancer Research (1999) 59:44-47.
Masuda et al., “Effects of Epigallocatechin-3-gallate on Growth, Epidermal Growth Factor Receptor Signaling Pathways, Gene Expression, and Chemosensitivity in Human Head and Neck Squamous Cell Carcinoma Cell Lines,” Clinical Cancer Research (2001) 7:4220-4229.
Dai et al., “Potentiation of Antitumor Effect Induced by Cytosine Arabinoside with (-30 )-Epigallocatechin-3-gallate in HL-60 Cells,” Chinese Hospital Pharmacy Journal (2002) 22:458-461.
Friberg, M., et al. “Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.” Int J Cancer. Sep. 10, 2002;101(2):151-5.
Gibbs, J.B., et al. “Antitumor efficacy of a farnesyltransferase inhibitor in transgenic mice.” Farnesyltransferase Inhibitors in Cancer Therapy, 2001:65-70.
DuHadaway James B.
Malachowski William
Muller Alexander J.
Prendergast George C.
Dan Dorfman Herrell & Skillman
Fetterolf Brandon
Lankenau Institute for Medical Research
Netter, Jr. Robert C.
Stone Christopher R
LandOfFree
Methods for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2756995